Efficacy of fexuprazan compared with rebamipide in Korean patients with gastritis: A matching-adjusted indirect comparison

Table 4 Outcome measures of fexuprazan (2 wk) vs rebamipide (4 wk)

	Fexuprazan 10 mg BID[3], before matching (n = 102)	Fexuprazan 10 mg BID[3], after matching (n = 87.51)	Rebamipide 100 mg TID[16] (n = 99)
Erosion improvement rate	65.7	64.2	60.6
Risk difference (95%CI)	5.1 (-8.2, 18.4)	3.6 (-9.8, 17.0)
P value	0.455	0.6
Erosion healing rate	57.8	51.2	53.5
Risk difference (95%CI)	4.3 (-9.4, 18.0)	-2.3 (-16.1, 11.5)
P value	0.538	0.744

¹Effective sample size was computed as the square of the summed weights divided by the sum of the squared weights.

Data are expressed as percentages of patients, unless specified otherwise.